Clinical relevance and advances in detection of translational biomarker cardiac troponin

被引:2
|
作者
Durairaj, Brindha [1 ,2 ]
Mohandass, Swathanthiram [1 ]
Sakthivel, Kunnathur Murugesan [1 ]
Poornima, Arthanareshwarar Arunachalam [1 ]
机构
[1] PSG Coll Arts & Sci, Dept Biochem, Civil Aerodrome Post, Coimbatore 641014, Tamil Nadu, India
[2] PSG Coll Arts & Sci, Civil Aerodrome Post, Coimbatore 641014, India
关键词
Cardiovascular disease; Cardiac troponin I; POC diagnosis; Biosensors; Clinical diagnosis; MYOCARDIAL-INFARCTION; CHEMILUMINESCENCE IMMUNOASSAY; ELECTROCHEMICAL BIOSENSORS; VENTRICULAR DYSFUNCTION; GOLD NANOPARTICLES; EUROPEAN-SOCIETY; SKELETAL-MUSCLE; I ELEVATION; ASSAYS; DETERMINANTS;
D O I
10.1016/j.ab.2024.115505
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cardiovascular diseases (CVD) are a range of diseases, pointing the functional hindrances in the heart and blood vessels of the human system that contributes to 48.6 % of the world 's adult death rate. The diagnosis of CVD relies upon the Electro Cardio Gram (ECG) and detection of muscle markers such as troponins. Among the cardiac trio, Cardiac Troponin I (cTnI) weighing 23 KiloDalton (kDa) is a sorted biomarker for CVD. cTnI remains high in the blood after 1 -2 weeks of myocardial damage. Testing of cTnI in CVD patients aids in diagnosis and risk stratification of the disease. Different determination systems including optical, electrochemical, and acoustic have been put forward for monitoring the cTnI which are Point of Care (POC) that promotes simple and sensitive detection of cTnI. The modern era has paved way to high-sensitivity Troponin I (hscTnI) devices that can detect up to 0.01 ng/ml in human blood/plasma/serum. Yet, the practice of hscTnI is impracticable due to cost inefficiency. Development of new hscTnI devices with minimal investment and maximal detection range will meet the global requirement. This review gives an over view on different detection systems of cardiac troponin I which stands as a translational detection molecule for CVDs.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Troponin: the biomarker of choice for the detection of cardiac injury. (vol 173, pg 1191, 2005)
    Babuin, L
    Jaffe, AS
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (03) : 353 - 353
  • [22] Cardiac troponin T is a sensitive and specific biomarker of cardiac injury in laboratory
    Beck, ML
    Dameron, GW
    Kang, YJ
    Erickson, BK
    DiBattista, TH
    Miller, KE
    Jackson, KN
    Mittelstadt, S
    OBrien, PJ
    CLINICAL CHEMISTRY, 1997, 43 : 395 - 395
  • [23] Fabrication and Characterization of Aluminium Interdigitated Electrode Hybrid with ZnO for Cardiac Troponin T Biomarker Detection
    Iswary, Letchumanan
    Nazri, N. F. N.
    Arshad, M. K. Md
    Fathil, M. F. M.
    Nuzaihan, M. M. N.
    Gopinath, Subash C. B.
    4TH ELECTRONIC AND GREEN MATERIALS INTERNATIONAL CONFERENCE 2018 (EGM 2018), 2018, 2045
  • [24] Relevance of Cardiac Troponin in Predicting Postoperative Myocardial Infarction
    Pangi, Manish
    Govindaiah, Satish
    Siddaiah, Vivekananda
    Samraaj, Jedidaiah
    RESEARCH IN CARDIOVASCULAR MEDICINE, 2020, 9 (04) : 94 - 99
  • [25] Seasonality of the Cardiac Biomarker Troponin in the Eastern Croatian Population
    Mikic, Misel
    Sestak, Anamarija
    Volaric, Mile
    Rudan, Stjepan
    Majnaric, Ljiljana Trtica
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [26] The clinical relevance of raised cardiac troponin I in the absence of significant angiographic coronary artery disease
    Nageh, T
    Sherwood, RA
    Wainwright, RJ
    Shah, AM
    Thomas, MR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (02) : 325 - 330
  • [27] Troponin I as a biomarker of cardiac injury in dogs with sepsis
    Pereira, C. S.
    Muzzi, R. A. L.
    Figueiredo, V. C.
    Muzzi, L. A. L.
    Oberlender, G.
    Junior, A. C. C. L.
    Neto, M. L.
    Oliveira, M. M.
    ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA, 2016, 68 (04) : 919 - 926
  • [28] Troponin as a Biomarker of Cardiac Toxicity: Past, Present, and Future
    Reagan, William J.
    TOXICOLOGIC PATHOLOGY, 2010, 38 (07) : 1134 - 1137
  • [29] Editorial: Advances in Cardiac Pacing and Neural Control Strategies: Basic, Translational and Clinical Research
    Kulkarni, Kanchan
    Salavatian, Siamak
    Stavrakis, Stavros
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [30] Clinical and Translational Advances in Glioma Immunotherapy
    Bunse, Lukas
    Bunse, Theresa
    Kraemer, Christopher
    Chih, Yu-Chan
    Platten, Michael
    NEUROTHERAPEUTICS, 2022, 19 (06) : 1799 - 1817